RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration RETINALGENIX AND MEDSAN CONTRACT TO ADVANCE STUDY INTENDED TO PERSONALIZE MEDICAL EVALUATIONS FOR PATIENTS RECEIVING TREATMENT FOR WET MACULAR DEGENERATION

Diabetic Retinopathy Market to Reach USD 13.04 billion By 2026 | Reports And Data Factors contributing to high CAGR are growing prevalence of diabetes along with rising incidence of blindness. Moreover, increase in purchasing power and the dread of losing vision have augmented the...